LCD ID number: L33998 (Florida/Puerto Rico/U.S. Virgin Islands)
July 3, 2018Fulvestrant (Faslodex) — revision to the Part A and Part B LCD
Based on a local coverage determination (LCD) reconsideration request for fulvestrant (Faslodex), the “Coverage Indications, Limitations, and/or Medical Necessity” section of the LCD was revised to add the indications for uterine neoplasms, endometrial carcinoma, and uterine leiomyosarcoma. In addition, ICD-10-CM diagnosis codes C54.0-C54.9 and C55 were added to the “ICD-10 Codes that Support Medical Necessity” section of the LCD for Healthcare Common Procedure Coding System (HCPCS) code J9395.
Effective Date – This LCD revision is effective for claims processed on or after June 14, 2018, for services rendered on or after August 1, 2016
Source: https://medicare.fcso.com